Sanofi, DNDi announce three-year research collaboration for neglected tropical diseases

The pharmaceutical company Sanofi and the Drugs for Neglected Diseases initiative (DNDi) on Monday announced a three-year research collaboration to develop drugs for nine neglected tropical diseases, RTTNews reports. The diseases include leishmaniasis, Chagas disease, human African trypanosomiasis, lymphatic filariasis, onchocerciasis, soil-transmitted helminthiasis, and dracunculiasis, fascioliasis, and schistosomiasis (5/30). According to a joint press release (.pdf), "The public sector will benefit from the drugs developed through this agreement under the best possible conditions to ease access for patients in all endemic countries, irrespective of their level of economic development" (5/30).

http://www.kaiserhealthnews.orgThis article was reprinted from with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Research evaluates the effects of physical agents on male fertility